Vivos Therapeutics, Inc. (VVOS) — Dilution Risk Analysis

Current Snapshot

Vivos Therapeutics, Inc. (VVOS) has a DilutionWatch score of 82/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
20,118,023 Source
Public Float
12,046,618 Source
Float as % of Outstanding
59.9%

Dilution Risk Score

Score: 82/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 8-K 3, 3 2, 4 1, S-3 1, XBRL 2.

FormFiledAccession
8-K 2026-04-22 0001493152-26-018562
3 2026-04-10 0002114460-26-000002
8-K 2026-04-03 0001493152-26-015132
4 2026-04-02 0002074003-26-000008
S-3 2026-02-17 0001493152-26-006829
3 2026-02-13 0001493152-26-006835
8-K 2026-01-20 0001493152-26-002844
xbrl 2025-12-31 xbrl-6598-xbrl_convertible
xbrl 2025-12-31 xbrl-6598-xbrl_warrant

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 1 months Source
Three-year share count growth 1244.39% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 82/10) Source
Cash Runway
1 months Source
Share Count Growth (3-Year)
1244.39% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.